Native T1 Mapping for the Diagnosis of Myocardial Fibrosis in Patients With Chronic Myocardial Infarction
- PMID: 36481075
- DOI: 10.1016/j.jcmg.2022.09.011
Native T1 Mapping for the Diagnosis of Myocardial Fibrosis in Patients With Chronic Myocardial Infarction
Abstract
Background: Myocardial fibrosis is a fundamental process in cardiac injury. Cardiac magnetic resonance native T1 mapping has been proposed for diagnosing myocardial fibrosis without the need for gadolinium contrast. However, recent studies suggest that T1 measurements can be erroneous in the presence of intramyocardial fat.
Objectives: The purpose of this study was to investigate whether the presence of fatty metaplasia affects the accuracy of native T1 maps for the diagnosis of myocardial replacement fibrosis in patients with chronic myocardial infarction (MI).
Methods: Consecutive patients (n = 312) with documented chronic MI (>6 months old) and controls without MI (n = 50) were prospectively enrolled. Presence and size of regions with elevated native T1 and infarction were quantitatively determined (mean + 5SD) on modified look-locker inversion-recovery and delayed-enhancement images, respectively, at 3.0-T. The presence of fatty metaplasia was determined using an out-of-phase steady-state free-precession cine technique and further verified with standard fat-water Dixon methods.
Results: Native T1 mapping detected chronic MI with markedly higher sensitivity in patients with fatty metaplasia than those without fatty metaplasia (85.6% vs 13.3%) with similar specificity (100% vs 98.9%). In patients with fatty metaplasia, the size of regions with elevated T1 significantly underestimated infarct size and there was a better correlation with fatty metaplasia size than infarct size (r = 0.76 vs r = 0.49). In patients without fatty metaplasia, most of the modest elevation in T1 appeared to be secondary to subchronic infarcts that were 6 to 12 months old; the T1 of infarcts >12 months old was not different from noninfarcted myocardium.
Conclusions: Native T1 mapping is poor at detecting replacement fibrosis but may indirectly detect chronic MI if there is associated fatty metaplasia. Native T1 mapping for the diagnosis and characterization of myocardial fibrosis is unreliable.
Keywords: MRI; T1 mapping; cardiac magnetic resonance; chronic myocardial infarction; fatty metaplasia; fibrosis.
Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures Supported in part with a grant from Guerbet, LLC. The funders had no role in the design of the trial; the collection, analysis, or interpretation of the data; or the writing or approval of the manuscript. Drs Kim and Judd are inventors on a U.S. patent on Delayed-Enhancement MRI, which is owned by Northwestern University. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment in
-
Can Chronic Myocardial Infarction Be Detected by Native T1 Mapping?JACC Cardiovasc Imaging. 2022 Dec;15(12):2080-2081. doi: 10.1016/j.jcmg.2022.09.012. Epub 2022 Nov 16. JACC Cardiovasc Imaging. 2022. PMID: 36481076 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical